Protea Biosciences' IPO

Protea Biosciences raised a round of funding on April 11, 2014. Investors include Public.

Protea is a leader in the emerging field of Bioanalytics. The company develops new technology for the identification, characterization, and quantitation of biologically-important molecules for basic r…

Articles about Protea Biosciences' IPO: